Susquehanna International Group, LLP Orchard Therapeutics PLC Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.7 - $1.51 $47,225 - $101,872	-67,465 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $21,535 - $41,399	-18,565 Reduced 21.58%	67,465 $89,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $62,623 - $119,935	27,957 Added 48.14%	86,030 $198,000
Q2 2021 Aug 11, 2021	SELL	$4.39 - $7.23 $449,860 - $740,887	-102,474 Reduced 63.83%	58,073 $255,000
Q1 2021 May 17, 2021	SELL	$4.39 - $9.08 $32,121 - $66,438	-7,317 Reduced 4.36%	160,547 $1.17 Million

Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $563,583 - $740,250	146,006 Added 667.98%	167,864 $725,000
Q3 2020 Nov 16, 2020	BUY	$4.11 - $6.45 $89,836 - $140,984	21,858 New	21,858 $90,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.